Blog
Facebook Is Making a $5.7 Billion Bet on India
Earlier this week, social networking giant Facebook (NASDAQ: FB) announced a massive $5.7 billion investment in Jio Platforms. Jio is a subsidiary of Reliance Industries, a multinational
Is It Too Late to Buy Gilead Sciences?
Gilead Sciences (NASDAQ: GILD) has been making waves of late. The company's antiviral drug, remdesivir, is currently perceived as the most promising potential treatment for COVID-19. As a result
Thinking About Buying Coronavirus Stocks? Answer This Question First
Since the beginning of the year, all three major market indexes are down. For instance, the S&P 500 is down by 12.6% year to date, while the Dow Jones Industrial Average is down by 18.3% over the
Retirement Concerns Are Booming Because of COVID-19
COVID-19 isn't just making hundreds of thousands of Americans sick; it's also been hammering the economy since it first took hold in the U.S. Not only have millions lost their jobs, but many
Is It Too Late to Buy Shares of Seattle Genetics?
As the overall market declined amid the coronavirus outbreak, Seattle Genetics (NASDAQ: SGEN) shares resisted, climbing 22% since the start of this year. The reason is simple: It's all about
This High-Yield Oil Major Is Cutting Spending More Than You Think
The energy industry is in the middle of a commodity downturn. While that's not unusual, this particular trough is unique and likely to linger. In response, Chevron (NYSE: CVX), along with many
Raytheon Tops Lockheed Martin for $10 Billion Cruise Missile Contract
On April 17, the U.S. Air Force ended the competition to develop a new Long-Range Standoff Weapon (LRSO) nearly two years early, declaring Raytheon Technologies (NYSE: RTX) the winner of a contract
Aurora Cannabis: A Trio of Writedowns Likely Awaits
The past 12-plus months have not been kind to marijuana stock investors. Following many years of outperformance and a first quarter (of 2019) that saw more than a dozen popular pot stocks gain at
2 Solid Reports Give Hope to Semiconductor Investors
Two semiconductor giants kicked off the sector's earnings season with some good news in the COVID-19 era. Both Texas Instruments (NASDAQ: TXN) and STMicroelectronics (NYSE: STM) presented solid
5 Things You Should Do If Your Employer Goes Under Due to COVID-19
Alongside the dreadful human toll, the COVID-19 pandemic is decimating businesses as well. Many companies forced to close due to social-distancing restrictions are now struggling to stay afloat. The
Will Citigroup's Credit Cards and Commercial Real Estate Drag It Down Going Forward?
Like all of its peers, Citigroup (NYSE: C) is adjusting to the new Current Expected Credit Loss (CECL) framework and announced big provisions for future loan losses when it reported first-quarter
Apple Stock: Buy, Sell, or Hold?
While many stocks have rebounded sharply since the coronavirus market crash in February and March, some still remain well below recent highs. Apple (NASDAQ: AAPL) is one of those stocks. Shares are
Better Buy: Amgen vs. Johnson & Johnson
If you're the kind of investor who likes to go big or go home, Amgen (NASDAQ: AMGN) and Johnson & Johnson (NYSE: JNJ) might be right up your alley. Amgen ranks as the biggest biotech in terms of
3 Things to Consider Before Raiding Your Retirement Fund to Pay the Bills
The coronavirus pandemic has turned the world upside down, wreaking havoc on people's health, the world economy, and job security.
Approximately 22 million Americans have filed for unemployment
3 Top Growth Stocks to Buy Right Now
There's no better way to earn life-changing wealth in the stock market than growth investing. Well-chosen growth stocks can deliver returns of 10, 20, and even 100 times or more your original
Pfizer Targets Summer For COVID-19 Vaccine Human Trials; Potential Treatment Also In The Works.
When Pfizer (NYSE: PFE) announced on April 9 that its five-point plan included a promising coronavirus treatment and a potential vaccine candidate in the works, shares soared to their highest point
Trulieve Rolls Toward a Strong Position in the Pot Industry
Trulieve (OTC: TCNNF), a Florida-based seed-to-sale company with 46 medical marijuana dispensaries in the Sunshine State, has been able to adjust smoothly to varying customer demand posed by the
These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?
An initial public offering (IPO) has a special allure: It draws in speculative investors eager to see stocks soar in the initial days of trading. In weak markets, only the strongest candidates pull
Didn't Get a Coronavirus Stimulus Check? Here's How to Fix It
Most Americans with income under qualifying rates will receive a coronavirus stimulus check (technically, an "Economic Impact Payment," and in most cases, it will come as a direct deposit and not a
Better Buy: AbbVie vs. Gilead Sciences
AbbVie (NYSE: ABBV) and Gilead Sciences (NASDAQ: GILD) are names you might be hearing a lot these days. AbbVie is in the process of acquiring Botox maker Allergan (NYSE: AGN) to boost its growth
2020 Social Security Trustees Report: 5 Must-Know Facts About Your Retirement Benefits
The coronavirus pandemic has pushed other, less immediate worries into the background, as everyone from government officials to first responders and ordinary people do what they can to protect
3 401(k) Mistakes to Avoid During the COVID-19 Crisis
Millions of Americans have already been impacted financially by COVID-19, and if you're one of them, that could change the way you plan and save for retirement. But the more careful you are with
3 Warren Buffett Stocks to Avoid at All Costs
While debatable, there's probably not a more revered investor than Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett. Having begun with $10,000 in seed capital in the 1950s, Buffett
5 Small Bank Stocks That Could Do Well During a Downturn
The coronavirus pandemic has had an outsized effect on the banking sector, as lenders brace for loan losses brought on by the economic shutdown. As of Wednesday's close, the KRE regional bank index
5 Smart Stocks to Buy During a Stock Market Crash
As you've probably learned one way or another over the past two months, stock market corrections, and even bear markets (i.e., declines of at least 20% from a recent high), are an inevitable part of


